ALTERATION OF THE CYTOPLASMIC ENDONUCLEASE CLEAVAGE PATTERN OF SV-40 DEOXYRIBONUCLEIC ACID IN THE PRESENCE OF ATP, ACTINOMYCIN D AND ETHIDIUM BROMIDE.CIOBANU N; SMELT D.1977; REV. ROUMAINE MED., VIROL.; ROUMAN.; DA. 1977; VOL. 28; NO 1; PP. 15-21; BIBL. 25 REF.Article

CONTACT INHIBITION OF THE MOVEMENT OF HYDROGEN IONS OUT OF ERYTHROCYTESGANCEVICI G; GHITESCU I; CIOBANU N et al.1973; ARCH. ROUMAIN. PATHOL. EXPER. MICROBIOL.; ROUMAIN; DA. 1973; VOL. 32; NO 1; PP. 131-144; ABS. RUSSE FR.; BIBL. 24 REF.Serial Issue

Malignant lymphomas, AIDS, and the pathogenic role of Epstein-Barr virusCIOBANU, N; WIERNIK, P. H.The Mount Sinai journal of medicine. 1986, Vol 53, Num 8, pp 627-638, issn 0027-2507Article

Coherently controlled emission from two atoms dressed via a standing wave laser fieldENAKI, N. A; CIOBANU, N; ORSZAG, M et al.Journal of physics. B. Atomic, molecular and optical physics (Print). 2011, Vol 44, Num 21, issn 0953-4075, 215502.1-215502.9Article

Quantum beats and localization of two atoms in the subwavelength regimeCIOBANU, N; ENAKI, N. A; ORSZAG, M et al.Journal of physics. B. Atomic, molecular and optical physics (Print). 2013, Vol 46, Num 15, issn 0953-4075, 155501.1-155501.8Article

Plasma cell leukemia with an unusual karyotype and prolonged survival with oral alkylating agent therapyWIERNIK, P. H; SCIORTINO, D; PAIETTA, E et al.Journal of cancer research and clinical oncology. 1987, Vol 113, Num 6, pp 576-578, issn 0171-5216Article

Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors : an eastern cooperative oncology group (ECOG) studyLAZARUS, H. M; GRAY, R; CIOBANU, N et al.Bone marrow transplantation (Basingstoke). 1994, Vol 14, Num 3, pp 443-448, issn 0268-3369Article

Transformation of myeloma into Ph¹-negative CML with plasma cell antigensPAIETTA, E; GOLDSTEIN, M; PAPENHAUSEN, P et al.American journal of hematology. 1985, Vol 19, Num 3, pp 289-292, issn 0361-8609Article

Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin 2 = Défaut de production de l'interleukine 2 chez les malades après une greffe de moelle et restauration in vitro de la prolifération défectueuse par l'interleukine 2 hautement purifiéeWELTE, K; CIOBANU, N; MOORE, M. A. S et al.Blood. 1984, Vol 64, Num 2, pp 380-385, issn 0006-4971Article

Pilot study of high-dose mitoxantrone and busulfan plus autologous bone transplantation in patients with advanced malignanciesKHALIL, A; CIOBANU, N; SPARANO, J. A et al.Bone marrow transplantation (Basingstoke). 1995, Vol 15, Num 1, pp 93-97, issn 0268-3369Article

Experience with autologous bone marrow harvesting and transfusion of marrow-derived red cellsCIOBANU, N; WEINBERG, V; SPARANO, J. A et al.Transfusion (Philadelphia, PA). 1992, Vol 32, Num 3, pp 231-234, issn 0041-1132Article

CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantationCIOBANU, N; RUNOWICZ, C. D; WIERNIK, P. H et al.American journal of obstetrics and gynecology. 1989, Vol 160, Num 2, pp 354-355, issn 0002-9378Article

Reversible central nervous system toxicity associated with high-dose chlorambucil in autologous bone marrow transplantation for ovarian carcinomaCIOBANU, N; RUNOWICZ, C; GUCALP, R et al.Cancer treatment reports. 1987, Vol 71, Num 12, pp 1324-1325, issn 0361-5960Article

Cefoperazone/sulbactam versus cefoperazone plus mezlocillin : empiric therapy for febrile, neutropenic bone marrow transplant patientsLAZARUS, H. M; CREGER, R. J; GUCALP, R et al.International journal of antimicrobial agents. 1996, Vol 7, Num 2, pp 85-91, issn 0924-8579Article

Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alphaSPARANO, J. A; DUTCHER, J. P; GRIMA, K et al.Cancer. 1991, Vol 68, Num 7, pp 1538-1544, issn 0008-543XArticle

Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correction by interleukin 2CIOBANU, N; WELTE, K; MERTELSMANN, R et al.Journal of clinical immunology. 1983, Vol 3, Num 4, pp 332-340, issn 0271-9142Article

Survival after phase II treatment of advanced renal cell carcinoma with taxol or high-dose interleukin-2WALPOLE, E. T; DUTCHER, J. P; WIERNIK, P. H et al.Journal of immunotherapy. 1993, Vol 13, Num 4, pp 275-281, issn 1053-8550Article

High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphomaLAZARUS, H. M; CRILLEY, P; SOEGIARSO, W et al.Journal of clinical oncology. 1992, Vol 10, Num 11, pp 1682-1689, issn 0732-183XArticle

Hypovitaminosis C in patients treated with high-dose interleukin 2 and lymphokine-activated killer cellsMARCUS, S. L; PETRYLAK, D. P; DUTCHER, J. P et al.The American journal of clinical nutrition. 1991, Vol 54, Num 6, pp 1292S-1297S, issn 0002-9165Conference Paper

Laboratory correlates of adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells in humansBOLDT, D. H; MILLS, B. J; ATKINS, M. B et al.Cancer research (Baltimore). 1988, Vol 48, Num 15, pp 4409-4416, issn 0008-5472Article

Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin busulfan/etoposide/cyclophosphamide in lymphoid malignanciesCRILLEY, P; LAZARUS, H; SOEGIARSO, W et al.Seminars in oncology. 1993, Vol 20, Num 4, pp 50-54, issn 0093-7754, SUP4Conference Paper

Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniquesROSS, A. A; COOPER, B. W; WINTER, C et al.Blood. 1993, Vol 82, Num 9, pp 2605-2610, issn 0006-4971Article